tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MIST Stock Latest News

Milestone partner announces Phase 3 study of etripamil met primary endpoint
The FlyMilestone partner announces Phase 3 study of etripamil met primary endpoint
14d ago
MIST
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
PremiumPress Releases
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
14d ago
MIST
Milestone Pharmaceuticals Welcomes New Directors and Auditor
PremiumCompany Announcements
Milestone Pharmaceuticals Welcomes New Directors and Auditor
16d ago
8K
MIST
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
PremiumThe Fly
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
16d ago
MIST
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
PremiumPress Releases
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
16d ago
MIST
Milestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe FlyMilestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
29d ago
MIST
Milestone Pharmaceuticals’ Promising Drug Advancements
Premium
Company Announcements
Milestone Pharmaceuticals’ Promising Drug Advancements
1M ago
MIST
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
Premium
Company Announcements
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
1M ago
MIST
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
PremiumThe Fly
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
1M ago
MIST
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
PremiumPress Releases
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
1M ago
MIST
Milestone Pharmaceuticals Bolsters Board with New Directors
PremiumCompany Announcements
Milestone Pharmaceuticals Bolsters Board with New Directors
2M ago
MIST
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
PremiumThe Fly
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
2M ago
ARVN
MIST
Milestone Pharmaceuticals Refreshes Board of Directors
PremiumPress ReleasesMilestone Pharmaceuticals Refreshes Board of Directors
2M ago
MIST
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
Premium
Press Releases
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
3M ago
MIST
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
Premium
Press Releases
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
4M ago
MIST
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
PremiumThe Fly
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
4M ago
MIST
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
PremiumPress Releases
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
4M ago
MIST
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
PremiumThe Fly
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
4M ago
MIST
Milestone Pharmaceuticals Excels with New Drug Update
PremiumCompany Announcements
Milestone Pharmaceuticals Excels with New Drug Update
4M ago
MIST
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
PremiumPress ReleasesMilestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
4M ago
MIST
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
Premium
The Fly
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
4M ago
MIST
Is MIST a Buy, Before Earnings?
Premium
Pre-Earnings
Is MIST a Buy, Before Earnings?
4M ago
MIST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >